Inbaraj Ganagarajan, Bajaj Sarita, Misra Puneet, Kandimalla Nandini, Thapa Abhishek, Ghosal Anit, Sharma Urveesh, Charles Pascal, Pobbati Harish, Hashmi Intkhab, Bansal Bhavit, de Vos Jacques, De Debasmita, Elshafei Omar, Garg Aditi, Basu-Ray Indranill
Medical Director, American Academy For Yoga in Medicine, Germantown, TN, 38139, USA.
Director-Professor and Head, Department of Medicine, Moti Lal Nehru Medical College, Allahabad, India.
Curr Probl Cardiol. 2025 Jun;50(6):103036. doi: 10.1016/j.cpcardiol.2025.103036. Epub 2025 Mar 23.
Obesity, a global epidemic, significantly increases cardiovascular disease (CVD) risk. Conventional treatments often lack long-term efficacy, emphasizing the need for integrative, sustainable approaches.
This review assesses the role of yoga as a complementary intervention in obesity management and its effectiveness in reducing cardiovascular risk.
We systematically reviewed literature up to March 2024 from Medline/PubMed, Scopus, Embase and the Cochrane Central Library. The focus was on randomized controlled trials (RCTs), observational studies, systematic reviews and meta-analyses evaluating the impact of yoga on obesity-related outcomes and cardiovascular risk factors. Studies were reviewed for quality, outcomes, and both physiological and psychological effects of yoga on obese individuals.
Yoga interventions consistently yielded positive results in reducing body mass index (BMI), waist circumference, and body fat. These physical changes correlate with significant improvements in cardiovascular markers, including blood-pressure, cholesterol levels, endothelial and autonomic functions. Yoga also enhances stress management and psychological well-being, addressing both mental and physical facets of obesity. The benefits extend beyond mere weight reduction, affecting systemic inflammation and metabolic health, crucial for mitigating CVD risks.
Yoga represents a promising, non-pharmacological approach to obesity management and CVD risk reduction. Its holistic impact on physical and psychological health makes it a viable adjunct therapy in comprehensive obesity management, fostering sustainable lifestyle changes and long-term health benefits.
Incorporating yoga into standard obesity management protocols could enhance therapeutic outcomes. Future research should standardize yoga interventions to better integrate them into modern healthcare and explore their long-term cardiovascular effects.
肥胖是一种全球性流行病,显著增加心血管疾病(CVD)风险。传统治疗方法往往缺乏长期疗效,这凸显了采用综合、可持续方法的必要性。
本综述评估瑜伽作为肥胖管理辅助干预措施的作用及其在降低心血管风险方面的有效性。
我们系统回顾了截至2024年3月来自Medline/PubMed、Scopus、Embase和Cochrane中央图书馆的文献。重点是随机对照试验(RCT)、观察性研究、系统评价和荟萃分析,这些研究评估了瑜伽对肥胖相关结局和心血管危险因素的影响。对研究的质量、结局以及瑜伽对肥胖个体的生理和心理影响进行了综述。
瑜伽干预在降低体重指数(BMI)、腰围和体脂方面始终产生积极结果。这些身体变化与心血管指标的显著改善相关,包括血压、胆固醇水平、内皮功能和自主神经功能。瑜伽还能增强压力管理和心理健康,解决肥胖的心理和生理方面问题。其益处不仅限于单纯的体重减轻,还影响全身炎症和代谢健康,这对降低心血管疾病风险至关重要。
瑜伽是一种有前景的非药物肥胖管理和降低心血管疾病风险的方法。它对身心健康的整体影响使其成为综合肥胖管理中可行的辅助治疗方法,促进可持续的生活方式改变和长期健康益处。
将瑜伽纳入标准肥胖管理方案可提高治疗效果。未来的研究应规范瑜伽干预措施,以便更好地将其融入现代医疗保健,并探索其长期心血管影响。